SAN DIEGO, April 8, 2009
LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES GOING CONCERN OPINION AND RECEIPT OF NASDAQ STAFF DEFICIENCY LETTER

SAN DIEGO, February 19, 2009
LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES REDUCTION IN WORKFORCE AND EVALUATES STRATEGIC OPTIONS

SAN DIEGO, February 11, 2009
LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES NEGATIVE RESULTS OF INTERIM EFFICACY ANALYSIS FOR RIQUENT PHASE 3 ASPEN TRIAL